A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape
- PMID: 11971028
- DOI: 10.4049/jimmunol.168.9.4772
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape
Abstract
HLA-G is a nonclassical MHC molecule with highly limited tissue distribution that has been attributed chiefly immune regulatory functions. Glioblastoma is paradigmatic for the capability of human cancers to paralyze the immune system. To delineate the potential role of HLA-G in glioblastoma immunobiology, expression patterns and functional relevance of this MHC class Ib molecule were investigated in glioma cells and brain tissues. HLA-G mRNA expression was detected in six of 12 glioma cell lines in the absence of IFN-gamma and in 10 of 12 cell lines in the presence of IFN-gamma. HLA-G protein was detected in four of 12 cell lines in the absence of IFN-gamma and in eight of 12 cell lines in the presence of IFN-gamma. Immunohistochemical analysis of human brain tumors revealed expression of HLA-G in four of five tissue samples. Functional studies on the role of HLA-G in glioma cells were conducted with alloreactive PBMCs, NK cells, and T cell subpopulations. Expression of membrane-bound HLA-G1 and soluble HLA-G5 inhibited alloreactive and Ag-specific immune responses. Gene transfer of HLA-G1 or HLA-G5 into HLA-G-negative glioma cells (U87MG) rendered cells highly resistant to direct alloreactive lysis, inhibited the alloproliferative response, and prevented efficient priming of cytotoxic T cells. The inhibitory effects of HLA-G were directed against CD8 and CD4 T cells, but appeared to be NK cell independent. Interestingly, few HLA-G-positive cells within a population of HLA-G-negative tumor cells exerted significant immune inhibitory effects. We conclude that the aberrant expression of HLA-G may contribute to immune escape in human glioblastoma.
Similar articles
-
The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.Brain. 2003 Jan;126(Pt 1):176-85. doi: 10.1093/brain/awg017. Brain. 2003. PMID: 12477705
-
Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.J Neuroimmunol. 2005 Feb;159(1-2):155-64. doi: 10.1016/j.jneuroim.2004.09.016. Epub 2004 Dec 28. J Neuroimmunol. 2005. PMID: 15652415
-
HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.J Immunol. 2008 Aug 15;181(4):2368-81. doi: 10.4049/jimmunol.181.4.2368. J Immunol. 2008. PMID: 18684926
-
Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells.Semin Cancer Biol. 2003 Oct;13(5):343-51. doi: 10.1016/s1044-579x(03)00025-7. Semin Cancer Biol. 2003. PMID: 14708714 Review.
-
The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.Semin Cancer Biol. 2003 Oct;13(5):353-9. doi: 10.1016/s1044-579x(03)00026-9. Semin Cancer Biol. 2003. PMID: 14708715 Review.
Cited by
-
The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy.Int J Mol Sci. 2021 Feb 17;22(4):1964. doi: 10.3390/ijms22041964. Int J Mol Sci. 2021. PMID: 33671123 Free PMC article. Review.
-
The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.Front Immunol. 2015 Feb 2;6:9. doi: 10.3389/fimmu.2015.00009. eCollection 2015. Front Immunol. 2015. PMID: 25699038 Free PMC article. Review.
-
HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells.Proc Natl Acad Sci U S A. 2004 May 4;101(18):7064-9. doi: 10.1073/pnas.0401922101. Epub 2004 Apr 21. Proc Natl Acad Sci U S A. 2004. PMID: 15103024 Free PMC article.
-
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy.J Neurooncol. 2003 Aug-Sep;64(1-2):13-20. doi: 10.1007/BF02700016. J Neurooncol. 2003. PMID: 12952282
-
European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer Treatment.Int J Mol Sci. 2019 Apr 12;20(8):1830. doi: 10.3390/ijms20081830. Int J Mol Sci. 2019. PMID: 31013867 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials